Kolon Life (Korea) Today
| 102940 Stock | KRW 30,900 250.00 0.82% |
PerformanceOK
| Odds Of DistressLow
|
Kolon Life is trading at 30900.00 as of the 22nd of March 2025, a 0.82 percent increase since the beginning of the trading day. The stock's open price was 30650.0. Kolon Life has less than a 9 % chance of experiencing financial distress in the next few years and had a ok performance during the last 90 days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
Kolon Life Science Inc. provides biopharmaceuticals, active pharmaceutical ingredients, antimicrobials, and water solutions primarily in South Korea. Kolon Life Science Inc. was founded in 2000 and is headquartered in Gwacheon, South Korea. Kolon Life is traded on Korean Securities Dealers Automated Quotations in South Korea.. The company has 11.41 M outstanding shares. More on Kolon Life Science
Moving against Kolon Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Kolon Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Kolon Life's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Kolon Life or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Pharmaceuticals, Healthcare (View all Sectors) |
Kolon Life Science (102940) is traded on KOSDAQ in Korea and employs 422 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 397.58 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kolon Life's market, we take the total number of its shares issued and multiply it by Kolon Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Kolon Life Science operates under Healthcare sector and is part of Pharmaceuticals industry. The entity has 11.41 M outstanding shares.
Kolon Life Science has accumulated about 27.8 B in cash with (16.19 B) of positive cash flow from operations.
Check Kolon Life Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Kolon Life Science is W397.58 Billion. Kolon Life Science holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Kolon Ownership Details
Kolon Life Science Risk Profiles
Although Kolon Life's alpha and beta are two of the key measurements used to evaluate Kolon Life's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.78 | |||
| Semi Deviation | 3.46 | |||
| Standard Deviation | 4.39 | |||
| Variance | 19.26 |
Kolon Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Kolon Life without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Kolon Life Corporate Management
Elected by the shareholders, the Kolon Life's board of directors comprises two types of representatives: Kolon Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kolon. The board's role is to monitor Kolon Life's management team and ensure that shareholders' interests are well served. Kolon Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kolon Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| WooSok Lee | Chief Officer | Profile | |
| SangWoo Lee | Managing Management | Profile | |
| SangJun Lee | Chief VicePres | Profile | |
| MunHee Park | Chief Officer | Profile | |
| SangHu Park | Managing Director | Profile | |
| TaeHwan Kim | President | Profile | |
| MyungKwan Suh | Managing Division | Profile |
Other Information on Investing in Kolon Stock
Kolon Life financial ratios help investors to determine whether Kolon Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kolon with respect to the benefits of owning Kolon Life security.